Visnagin, from Ammi visnaga, protects against doxorubicin-induced cardiomyopathy by inhibiting mitochondrial malate dehydrogenase, leading to reduced cardiomyocyte apoptosis.
| Formal Name | 4-Methoxy-7-methyl-5H-furo[3, 2-g][1]benzopyran-5-one |
|---|---|
| Purity | >98% |
| CAS Number | 82-57-5 |
| Formula | C13H10O4 |
| Molecular Weight | 230.22 |
| Appearance | Powder |
| Solubility | Dissolves in DMSO (up to 25 mg/mL) or in ethanol (up to 25 mg/mL). |
| Stability | ≥ 1 year |
| Application Procedures | First, dissolve in DMSO (up to 25 mg/mL) or in Ethanol (up to 25 mg/mL), and then dilute it into an aqueous buffer. Solutions in DMSO or ethanol can be stored at -20°C for up to 3 months. |
| Storage Information | -20°C |
Protects against doxorubicin-induced cardiomyopathy
Datasheet